Abstract:IMPORTANCE Extremely low diastolic blood pressure has been reported to be associated with increased adverse cardiovascular events (ie, the diastolic J-shape phenomenon); however, current US guidelines recommend an intensive blood pressure target of less than 130/80 mm Hg without mentioning the lower limits of diastolic blood pressure. OBJECTIVES To evaluate whether there is a diastolic J-shape phenomenon for patients with an treated systolic blood pressure of less than 130 mm Hg and to explore the safe and optimal diastolic blood pressure ranges for this patient population. DESIGN, SETTING, AND PARTICIPANTS This cohort study analyzed outcome data of patients at high cardiovascular risk who were randomized to intensive or standard blood pressure control and achieved treated systolic blood pressure of less than 130 mm Hg in the Systolic Blood Pressure Intervention Trial (SPRINT) and Action to Control Cardiovascular Risk in Diabetes-Blood Pressure (ACCORD-BP) trial. Data were collected from October 2010 to August 2015 (SPRINT) and from September 1999 to June 2009 (ACCORD-BP). Data were analyzed from January to May 2020. EXPOSURE Treated diastolic blood pressure, divided in intervals of less than 60, 60 to less than 70, 70 to less than 80, and 80 mm Hg and greater. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. A composite cardiovascular outcome, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, was among the key secondary outcomes. RESULTS A total of 7515 patients (mean [SD] age, 65.6 [8.7] years; 4553 [60.6%] men) were included in this analysis. The nominally lowest risk was observed at a diastolic blood pressure between 70 and 80 mm Hg for the primary outcome, the composite cardiovascular outcome, nonfatal myocardial infarction, and cardiovascular death. A mean diastolic blood pressure of less than 60 mm Hg was associated with significantly increased risk of the primary outcome (hazard ratio [HR], 1.46; 95% CI, 1.13-1.90; P = .004), the composite cardiovascular outcome (HR, 1.74; 95% CI, 1.26-2.41; P = .001), nonfatal myocardial infarction (HR, 1.73; 95% CI, 1.15-2.59; P = .008), and nonfatal stroke (HR, 2.67; 95% CI, 1.26-5.63; P = .01). CONCLUSIONS AND RELEVANCE This cohort study found that lowering diastolic blood pressure to less than 60 mm Hg was associated with increased risk of cardiovascular events in patients with high cardiovascular risk and an treated systolic blood pressure less than 130 mm Hg. The finding that a diastolic blood pressure value between 70 and 80 mm Hg was an optimum target for this patient population merits further study.

Cardiovascular Risks Associated With Diastolic Blood Pressure and Isolated Diastolic Hypertension

Cardiovascular Risk of Isolated Diastolic Hypertension Defined by the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline: A Nationwide Age-Stratified Cohort Study

Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure

Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension—Con Side of the Argument

CARDIOVASCULAR RISK IN TREATED HYPERTENSIVE PATIENTS WITH ISOLATED DIASTOLIC HYPERTENSION AND ISOLATED LOW DIASTOLIC BLOOD PRESSURE

Isolated diastolic hypertension and cardiovascular outcomes across different diagnostic guidelines: a systematic review and meta-analysis

Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prospective cohort study

ISOLATED DIASTOLIC BLOOD PRESSURE AND RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN A COMMUNITY DWELLING POPULATION

Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure As Distinct Outcome Predictors in 8341 Untreated People Recruited from 12 Populations.

Association between cardiovascular risk and diastolic blood pressure in older adults with systolic blood pressure less than 130mmHg: a prospective cohort study from 2014 to 2022

Isolated Diastolic Hypertension Associated Risk Factors among Chinese in Anhui Province, China

Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults

Systolic and Diastolic Blood Pressure Lowering As Determinants of Cardiovascular Outcome

SYSTOLIC AND DIASTOLIC BLOOD PRESSURE LOWERING AS DETERMINANTS OF CARDIOVASCULAR OUTCOME ON ANTIHYPERTENSIVE DRUG TREATMENT

Risks of Untreated and Treated Isolated Systolic Hypertension in the Elderly: Meta-Analysis of Outcome Trials

Evaluation of Optimal Diastolic Blood Pressure Range among Adults with Treated Systolic Blood Pressure Less Than 130 Mm Hg

Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants

Prevalence and clinical characteristics of isolated diastolic hypertension in untreated hypertensive outpatients

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China

Isolated diastolic hypertension in childhood and risk of adult subclinical target organ damage: a 30-year prospective cohort study